C. M. Black

3.4k total citations · 1 hit paper
33 papers, 2.5k citations indexed

About

C. M. Black is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, C. M. Black has authored 33 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Dermatology. Recurrent topics in C. M. Black's work include Systemic Sclerosis and Related Diseases (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Medical Imaging and Pathology Studies (5 papers). C. M. Black is often cited by papers focused on Systemic Sclerosis and Related Diseases (27 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Medical Imaging and Pathology Studies (5 papers). C. M. Black collaborates with scholars based in United Kingdom, United States and Germany. C. M. Black's co-authors include CP Denton, Bernard Coleiro, D Mukerjee, Gerry Coghlan, C Knight, Joseph Davar, Deepa George, Chris Denton, Jeremy Cailes and R M du Bois and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

C. M. Black

33 papers receiving 2.4k citations

Hit Papers

Prevalence and outcome in systemic sclerosis associated p... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
    2003 543 citations D Mukerjee, Deepa George et al. Annals of the Rheumatic Diseases profile →

Peers

C. M. Black
K.P. Tiev France
Paola Caramaschi Italy
Silvia Laura Bosello Italy
Maria Letizia Conforti Italy
A Akesson Sweden
Andreina Manfredi Italy
Dimitrios Daoussis Greece
G Tirri Italy
Srihari Veeraraghavan United States
H Courtois France
K.P. Tiev France
C. M. Black
Citations per year, relative to C. M. Black C. M. Black (= 1×) peers K.P. Tiev

Countries citing papers authored by C. M. Black

Since Specialization
Citations

This map shows the geographic impact of C. M. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. M. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. M. Black more than expected).

Fields of papers citing papers by C. M. Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. M. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. M. Black. The network helps show where C. M. Black may publish in the future.

Co-authorship network of co-authors of C. M. Black

This figure shows the co-authorship network connecting the top 25 collaborators of C. M. Black. A scholar is included among the top collaborators of C. M. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. M. Black. C. M. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goh, Nicole, Sujal R. Desai, Constantinos Anagnostopoulos, et al.. (2010). Increased epithelial permeability in pulmonary fibrosis in relation to disease progression. European Respiratory Journal. 38(1). 184–190. 32 indexed citations
3.
Matucci‐Cerinic, Marco, CP Denton, D.E. Furst, et al.. (2010). Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 70(1). 32–38. 322 indexed citations
4.
Nihtyanova, Svetlana I., et al.. (2009). A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis. Lara D. Veeken. 48(10). 1218–1221. 31 indexed citations
5.
Black, C. M., et al.. (2007). Using a self-reported functional score to assess disease progression in systemic sclerosis. Lara D. Veeken. 46(7). 1107–1110. 14 indexed citations
6.
Cherkas, Lynn, Frances M. K. Williams, Kevin Howell, et al.. (2007). Heritability of Raynaud's phenomenon and vascular responsiveness to cold: A study of adult female twins. Arthritis Care & Research. 57(3). 524–528. 12 indexed citations
7.
Abdallah, Atiyeh M., Elisabetta Renzoni, Anna L. Lagan, et al.. (2006). A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. International Journal of Immunogenetics. 33(3). 155–161. 14 indexed citations
8.
Lagan, Anna L., Panagiotis Pantelidis, Elisabetta Renzoni, et al.. (2004). Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Lara D. Veeken. 44(2). 197–201. 19 indexed citations
9.
Mukerjee, D, et al.. (2003). Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respiratory Medicine. 97(11). 1230–1236. 71 indexed citations
10.
Mukerjee, D, Deepa George, Bernard Coleiro, et al.. (2003). Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Annals of the Rheumatic Diseases. 62(11). 1088–1093. 543 indexed citations breakdown →
11.
Coleiro, Bernard, SE Marshall, Chris Denton, et al.. (2001). Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Lara D. Veeken. 40(9). 1038–1043. 153 indexed citations
12.
13.
Hansell, D.M., et al.. (1997). Functional Impairment in Lone Cryptogenic Fibrosing Alveolitis and Fibrosing Alveolitis Associated With Systemic Sclerosis: A Comparison. American Journal of Respiratory and Critical Care Medicine. 155(5). 1657–1664. 51 indexed citations
14.
Denton, Chris, et al.. (1997). Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Lara D. Veeken. 36(2). 239–243. 250 indexed citations
15.
Fanning, Gregory, Michael Bunce, C. M. Black, & K. I. Welsh. (1997). Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α. Tissue Antigens. 50(1). 23–31. 64 indexed citations
16.
Southcott, AM, Karen L. Jones, S Majumdar, et al.. (1995). Interleukin-8. Differential Expression in Lone Fibrosing Alveolitis and Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 151(5). 1604–1612. 73 indexed citations
17.
Denton, Christopher P., et al.. (1995). SERIAL CIRCULATING ADHESION MOLECULE LEVELS REFLECT DISEASE SEVERITY IN SYSTEMIC SCLEROSIS. Lara D. Veeken. 34(11). 1048–1054. 98 indexed citations
18.
Jewkes, R. F., et al.. (1995). ARTHRITIS IN SCLERODERMA. Lara D. Veeken. 34(9). 831–837. 43 indexed citations
19.
Briggs, David, Carol M. Artlett, Nancy J. Olsen, et al.. (1994). FAMILIAL SCLERODERMA—EVIDENCE FOR ENVIRONMENTAL VERSUS GENETIC TRIGGER. Lara D. Veeken. 33(12). 1131–1135. 18 indexed citations
20.
Briggs, David, et al.. (1993). The HLA‐DP locus in systemic sclerosis – No primary association. Tissue Antigens. 42(1). 144–145. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.P. Tiev Breakdown of academic impact, for papers by Paola Caramaschi Breakdown of academic impact, for papers by Silvia Laura Bosello Breakdown of academic impact, for papers by Maria Letizia Conforti Breakdown of academic impact, for papers by A Akesson Breakdown of academic impact, for papers by Andreina Manfredi Breakdown of academic impact, for papers by Dimitrios Daoussis Breakdown of academic impact, for papers by G Tirri Breakdown of academic impact, for papers by Srihari Veeraraghavan Breakdown of academic impact, for papers by H Courtois
Rankless by CCL
2026